ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,010.60
0.87%
US Tech 100
16,778.40
0.15%
Dow Jones
38,239.98
0.67%
Brent Oil
86.165
-0.28%
Bitcoin
66,115.49
-1.11%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Immupharma Plc (IMM) Quote

Immupharma Plc

Immupharma Plc (IMM)

Immutep Limited
International Metals Mining Corp
2.385
0.00
( 0.00% )
Updated: 05:46:58
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.385
Bid
2.21
Ask
2.35
Volume
21,468
0.00 Day's Range 0.00
0.83 52 Week Range 3.78
Market Cap
7.935M
Previous Close
2.385
Open
-
Last Trade
8123
@
2.3882
(O)
Last Trade Time
04:24:31
Financial Volume
-
VWAP
-
Average Volume (3m)
2,866,868
Shares Outstanding
333,403,115
Dividend Yield
-
PE Ratio
-2.09
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-3.81M

About Immupharma Plc

Sector
Finance Services
Industry
Finance Diversified
Website
www.immupharma.com
Headquarters
London, Gbr
Founded
2006
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.39p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares outstanding. The market capitalization of Immupharma is £7.93 million. Immupharma has a price to earnings ratio (PE ratio) of -2.09.

IMM Latest News

More News

Immupharma PLC Grant of Share Options

Immupharma PLC 19 April 2024                                                                                                                                                                     ...

April 19 2024
RNS Regulatory News

Immupharma jumps amid new IP strategy for P140 technology platform

Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and ...

April 02 2024
Alliance News

Immupharma PLC New intellectual property strategy initiated

Immupharma PLC 02 April 2024     02 April 2024   ImmuPharma PLC ("ImmuPharma" or the "Company")    New intellectual property strategy initiated to significantly enhance patent life and...

April 02 2024
RNS Regulatory News

Incanthera says first order from skincare deal doubles

ImmuPharma PLC on Monday noted updates on Incanthera PLC's commercial skincare deal with Marionnaud, which was first ...

March 25 2024
Alliance News

Immupharma PLC Incanthera provides Comm'l Update/Revenue F'casts

Immupharma PLC 25 March 2024   25 March 2024     ImmuPharma PLC ("ImmuPharma" or the "Company")   Incanthera Provides Commercial Update and Revenue Forecasts   ImmuPharma PLC (LSE AIM: IMM...

March 25 2024
RNS Regulatory News

Immupharma PLC Grant of Share Options

Immupharma PLC 19 March 2024                                                                                                                                                                     ...

March 19 2024
RNS Regulatory News

Immupharma PLC IMMUPHARMA AT BIO-EUROPE SPRING 2024

Immupharma PLC 14 March 2024   RNS REACH |14 March 2024       ImmuPharma PLC ("ImmuPharma" or the "Company")   IMMUPHARMA AT BIO-EUROPE SPRING 2024 18-20 March 2024 | Barcelona   ImmuPharma...

March 14 2024
RNS Non-Regulatory

EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up

The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not ...

March 06 2024
Alliance News

Immupharma PLC Financial, Business and Portfolio Develop't Update

Immupharma PLC 06 March 2024     RNS 06 March 2024   ImmuPharma PLC ("ImmuPharma" or the "Company")    Financial, Business and Portfolio Development Update   ImmuPharma PLC (LSE AIM: IMM...

March 06 2024
RNS Regulatory News

Immupharma PLC Holding(s) in Company

Immupharma PLC 28 December 2023 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...

December 28 2023
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0050.2100840336132.382.412.210083282.33390966DE
40.0853.695652173912.32.82.0620872742.37044879DE
120.93564.48275862071.452.90.8328668681.72613555DE
260.68540.29411764711.72.90.8319085541.70270317DE
52-0.515-17.75862068972.93.780.8314692992.00822899DE
156-6.535-73.26233183868.9210.60.8314214303.90030905DE
260-8.115-77.285714285710.5320.8313496307.48353549DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PEGYPineapple Energy Inc
$ 0.0623
(36.03%)
21.76M
HWHHWH International Inc
$ 1.71
(33.59%)
1.33M
IBRXImmunityBio Inc
$ 6.42
(29.96%)
1.09M
NUWENewellis Inc
$ 0.4261
(27.57%)
2.29M
HIBBHibbett Inc
$ 86.39
(19.18%)
9.9k
ABEOAbeona Therapeutics Inc
$ 3.90
(-47.01%)
46.43k
GWAVGreenwave Technology Solutions Inc
$ 0.0841
(-33.41%)
587.61k
TTOOT2 Biosystems Inc
$ 2.51
(-20.57%)
30.12k
HUGEFSD Pharma Inc
$ 0.4001
(-18.18%)
1
PHIOPhio Pharmaceuticals Corporation
$ 0.6884
(-17.05%)
9.11k
PEGYPineapple Energy Inc
$ 0.0623
(36.03%)
21.76M
NUWENewellis Inc
$ 0.4261
(27.57%)
2.29M
AGBAAGBA Group Holding Ltd
$ 2.92
(16.80%)
1.9M
JAGXJaguar Health Inc
$ 0.1522
(-15.40%)
1.55M
HWHHWH International Inc
$ 1.71
(33.59%)
1.33M

Discussion

View Full Feed
Freddie bagholder Freddie bagholder 5 minutes ago
You are absolutely correct on Sandra. I urge everyone here to ask your family and friends to vote for Trump. Else I can bet NWS will start after they reach $200b capital as per Calabria/mnuchin agreement
FNMA
TRUISM TRUISM 6 minutes ago
AMSilk Strengthens Management Team With Key Hires Of Ralph Fraundorfer And Ctibor Kohutovic To Management Board
NEWS PROVIDED BY AMSilk Apr, 23, 2024
https://www.prnewswire.co.uk/news-releases/amsilk-strengthens-management-team-with-key-hires-of-ralph-fraundorfer-and-ctibor-kohuto
KBLB
Seminole Red Seminole Red 7 minutes ago
after reading this post I think 5 jurors will go Not guilty

Meet the 12 New Yorkers on Trump’s hush money jury

https://thehill.com/regulation/court-battles/4612102-meet-trump-hush-money-criminal-trial-jury/?email=a847a43b9c99026a728b4bd541e637625305ce80&emaila=aecd5459b
sctts sctts 8 minutes ago
$$$$ Today is the Day $$$$

$$$$ $frx $$$$
FRX
cableguy cableguy 8 minutes ago
Why can't they, they have never had one, none listed on OTCMarkets.
ICTY
Monksdream Monksdream 9 minutes ago
NNVC under $2
https://investorshub.advfn.com/uimage/uploads/2024/4/23/hkeldIMG_7628.gif
NNVC
EZ2 EZ2 10 minutes ago
:-)
Monksdream Monksdream 11 minutes ago
NOTV under $5

https://investorshub.advfn.com/uimage/uploads/2024/4/23/rhc[pIMG_7627.gif
NOTV
Monksdream Monksdream 13 minutes ago
TBPH underb$10

https://investorshub.advfn.com/uimage/uploads/2024/4/23/cwqdpIMG_7626.gif
TBPH
Dead On Arrival Dead On Arrival 14 minutes ago
That is great news.
LWLG
Dead On Arrival Dead On Arrival 14 minutes ago
And the stock price is near 52 week lows. Stop worshiping these CEO's like they are rock stars.
LWLG
MrBiocide MrBiocide 15 minutes ago
Would love to know more about the UK NHS as we are also researching potential....
PCTL
ShadowDiviner72 ShadowDiviner72 18 minutes ago
Curious if we will see another PR in pre market today
JAGX
TRUISM TRUISM 19 minutes ago
Without producing a prototype or two, for testing durability, etc...

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse3.mm.bing.net%2Fth%3Fid%3DOIP.gCNRX2VMj_VRj6Y3XvSw4wHaE1%26pid%3DApi&f=1&ipt=8d3de0a75169fb00066d38fe9aaa51cc3cee41c1652cdea06e95fb3946e1baa5&ipo=images
KBLB
Nrdc92 Nrdc92 19 minutes ago
Not sure that answers your question, Walter. Lebby’s response is another question, the basis of which lacks any foundation. In others words, are they working on closing a deal with a big ubiquity-creating partner? And if so, why is that taking so long?

It’s another evasive response.
LWLG
ZRock ZRock 22 minutes ago
that's the conclusion I come too.
KSCP
Horsts Horsts 25 minutes ago
Looks like a lot of dilution is going on here
SPCB
monocle monocle 25 minutes ago
Hi ont, yep I remember you. I've been out for awhile too, still find the story compelling though. Don't worry message board pitch forks don't hurt lol
NB
gregcod gregcod 31 minutes ago
I know ACME has alot going for it..It entered into an agreement with Eagle Battery Metals , a private lithium and exploration company in Reno, Nevada..ACMEs Fish Lake Valley project is comprised of 207 lode mining claims totalling 4,139 acres located in Esmerelda County, Nevada.Next door is world c
ACLHF
monocle monocle 32 minutes ago
Why are you calculating reverse split prices? Those companies have not done a reverse split, they still trade OTC.

Interest from Stellantis and the letter from EXIM weren't announced until well after the merger was announced in Sept 2022. Niocorp first applied to EXIM in February 2023
NB
Mdv_BE Mdv_BE 33 minutes ago
Hi Jeunke,

could you please also share the info about LWLG from the conference in Antwerp with me?
marlincasleo@gmail.com

Alvast bedankt!
LWLG
tkg tkg 33 minutes ago
Incredible statistic just mentioned on CNBC...

"AMZN, AAPL, GOOG & META alone consumed more electricity than the country of Colombia in 2022"...wow!
AAPL AMZN GOOG
Monksdream Monksdream 36 minutes ago
SPAC junk
https://investorshub.advfn.com/uimage/uploads/2024/4/23/ejrsjIMG_7625.gif
HWH
floblu14 floblu14 38 minutes ago
Media recognition & coverage -

Pharmaceutical Technology -
April 22

Enanta Pharmaceuticals gets grant for inhibiting coronavirus replication with compound of formula
Enanta Pharmaceuticals has been granted a patent for compounds that inhibit coronavirus r
ENTA
moola26 moola26 40 minutes ago
Good morning bioamber shareholders !!
Majority holding strong!!!

Your Recent History

LSE
IMM
Immupharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved